| Literature DB >> 35747055 |
Abstract
The limbic system (LS) coordinates an important role in memory generation, creating an emotional response to stress, and helping regulate autonomic and endocrine functions. Dysfunction of the limbic system can present secondary to many pathologies including autoimmune, infectious, paraneoplastic, etc. Lesions to the limbic system can also lead to varying symptoms which can be challenging for physicians to correctly identify and treat. Here we report a 59-year-old male with aggressive mood changes and acute onset of auditory and visual hallucinations. The cerebrospinal fluid (CSF) and serum immunological antibody panel confirmed the presence of voltage-gated potassium channel (VGKC) antibodies. Significant radiographic findings included an MRI revealing T2 hyperintensities in the bilateral hippocampus. Paraneoplastic screening with testicular ultrasound and chest CT was completed and was negative. A primary diagnosis of voltage-gated potassium channel limbic encephalitis (VGKC-LE) was made. Management included five days of intravenous immunoglobulin (IVIG) with subsequent resolution of symptoms. The limbic system is an intricate network of neurons that generates and relays key information to other parts of the brain. Its function and, in this case, its dysfunction remain an area of continued research. This case aimed to highlight the importance of recognizing the clinical presentation and objective findings of a rare type of autoimmune encephalitis and identifies the significance of paraneoplastic screening.Entities:
Keywords: autoimmune limbic encephalitis; cancer; clinical psychiatry; hippocampus; neuro immunology; neurology; paraneoplastic; potassium channel; psychiatry; voltage gated potassium channel autoimmune encephalitis
Year: 2022 PMID: 35747055 PMCID: PMC9209402 DOI: 10.7759/cureus.25186
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Cerebrospinal fluid (CSF) and serum immunological antibody panel.
PCR: polymerase chain reaction
| Lab parameters | Numerical values with reference range and units |
| Glucose, CSF | 90 mg/dL (50-80) |
| Protein, CSF | 42 mg/dL (15-45) |
| Red blood cell (RBC), CSF | 3 (0) |
| Appearance, CSF | Clear |
| White blood cell (WBC), CSF | 1 |
| Venereal disease research laboratory (VDRL), CSF | Nonreactive |
| Lymphocytes %, CSF | 40% |
| Mono/macrophage %, CSF | 60% |
| Total cells counted, CSF | 5 |
| Immunoglobulin G (IgG), CSF | 6.2 mg/dL (0.0-6.0) |
| Albumin, CSF | 20 mg/dL (0-35) |
| Albumin nephelometry | 2590 mg/dL (3500-5200) |
| Albumin index | 7.7 (0.0-9.0) |
| Immunoglobulin G index | 0.46 (0.28-0.66) |
| CSF IgG/albumin ratio | 0.31 (0.09-0.25) |
| CSF oligoclonal bands | Negative |
| CSF IgG synthesis rate | <0.0 |
| Herpes simplex 1 PCR, CSF | Nonreactive |
| Herpes simplex 2 PCR, SF | Nonreactive |
|
| Nonreactive |
|
| Nonreactive |
|
| Nonreactive |
|
| Nonreactive |
| Cytomegalovirus DNA, CSF | Nonreactive |
| Enterovirus DNA, CSF | Nonreactive |
| Human herpesvirus 6 DNA, CSF | Nonreactive |
| Human parechoviruses DNA, CSF | Nonreactive |
|
| Nonreactive |
| John Cunningham (JC) virus quantitative PCR, CSF | Nonreactive |
| Alpha-1 globulin | 0.3 g/dL (0.2-0.3) |
| Alpha-2 globulin | 0.7 g/dL (0.5-0.9) |
| Gamma globulin | 1.5 g/dL (0.8-1.7) |
| Beta-1 globulin | 0.5 g/dL (0.4-0.6) |
| Beta-2 globulin | 0.3 g/dL (0.4-0.6) |
| Thyroid peroxidase antibody | 1 IU/mL (<9) |
| Acetylcholine receptor ganglionic | <53 (<53) |
| Anti-SOX 1 Ab | <11 (<11) |
| AMPAR receptor (AMPAR) 1 Ab | Negative |
| AMPA receptor (AMPAR) 2 Ab | Negative |
| Antiphysin Ab | <11 (<11) |
| Type 1 antineuronal nuclear antibody (ANNA1) Ab | <11 (<11) |
| Type 2 antineuronal nuclear antibody (ANNA2) Ab | <11 (<11) |
| Type 2 antineuronal nuclear antibody (ANNA3) Ab | Negative |
| Aquaporin 4 Ab | Negative |
| Contactin-associated protein-like 2 (CASPR-2) Ab | Negative |
| CV2/collapsin response-mediator protein-5 (CRMP5) Ab | <11 (<11) |
| Dipeptidyl peptidase-like protein 6 (DPPX) receptor Ab | Negative |
| Epstein-Barr virus DNA, quantitative | Not detected |
| Gamma-aminobutyric acid-B (GABA-B) receptor Ab | <11 (<11) |
| Glutamic acid decarboxylase 65 (GAD65) Ab | <11 (<11) |
| Leucine-rich glioma-inactivated protein 1 (LGI-1) Ab | Negative |
| Ma2/Ta Ab | <11 (<11) |
| Myelin Ab | Negative |
| N-methyl-D-aspartate receptor (NMDAR) Ab | Negative |
| Purkinje cell cytoplasmic (PCA) Ab | Negative |
| Purkinje cell cytoplasmic type 1 (PCA1) Ab | <11 (<11) |
| Voltage-gated calcium channel (VGCC) type N Ab | <55 (<55) |
| Voltage-gated potassium channel (VGKC) protein complex, Ab | 112 pmol/L (<80) |
| Voltage-gated calcium channel (VGCC) protein complex Ab | <30 pmol/L (<30) |
| Zinc protein 4 (Zic4) Ab | <11 (<11) |
Figure 1MRI brain with and without contrast T2/FLAIR images.
(A) MRI T2/FLAIR axial view and (B) MRI T2/FLAIR sagittal view.
FLAIR: fluid attenuated inversion recovery
Video 1Testicular ultrasound revealing no malignant lesions, cyst on the right testicular head.
Figure 2The circuit of Papez is a neural loop that helps regulate emotional expression.